Investigating human brain cells related to autism and schizophrenia
Brain-region-specific humanized cortical interneuron mice
This study is looking at special brain cells that help control how our brains work, and it's for people interested in understanding autism and schizophrenia better; by creating human-like brain cells from stem cells, researchers hope to learn how these cells behave and what might affect them in these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11093424 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of specific brain cells called GABAergic cortical interneurons, which are crucial for regulating brain activity. By creating human-like brain cells from stem cells, the study aims to explore how these cells function in individuals with autism spectrum disorders and schizophrenia. The researchers will analyze these cells in a lab setting to uncover the genetic and environmental factors that contribute to brain disorders. This approach allows for a more accurate representation of human brain function compared to traditional animal models.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autism spectrum disorders or schizophrenia.
Not a fit: Patients without neurodevelopmental disorders or those who do not have a genetic predisposition to these conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for autism and schizophrenia.
How similar studies have performed: Previous research has shown promise in using human-derived cells to study brain disorders, indicating potential for success in this novel approach.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Chung, Sangmi — Rutgers Biomedical and Health Sciences
- Study coordinator: Chung, Sangmi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.